Endogenous [ftcn]
Estradiol [horm, phsu, strd]
Metabolite [bacs]
atherosclerotic [ftcn]
formation [biof]
Female [fndg]
Apolipoprotein E [aapp, bacs]
Deficient [ftcn]
mice [mamm]
Estradiol [horm, phsu, strd]
Endogenous [ftcn]
Estrogen [horm, phsu, strd]
Experimental [qlco]
Atherosclerosis [dsyn]
2-methoxyestradiol [phsu, strd]
Blood Cells [cell]
Currently [tmco]
Evaluation [ftcn]
Clinical Trials [resa]
2-methoxyestradiol [phsu, strd]
arrested [dsyn]
Cell Proliferation [celf]
Classical [qlco]
Estrogen Receptors [aapp, rcpt]
Study [mnob]
Examined [fndg]
2-methoxyestradiol [phsu, strd]
Affect [menp]
Atherosclerosis [dsyn]
Female [fndg]
mice [mamm]
Apolipoprotein E [aapp, bacs]
Deficient [ftcn]
mice [mamm]
Well [qlco]
Established [qlco]
Mouse Model [emod]
Atherosclerosis [dsyn]
treated [topp]
Slow [qlco]
Release [hlca]
pellets [bodm]
placebo [topp]
17 beta-Estradiol [horm, phsu, strd]
Mu [inpr]
g d [qnco]
2-methoxyestradiol [phsu, strd]
Mu [inpr]
g d [qnco]
Low dose [qnco]
Mu [inpr]
g d [qnco]
High dose [qnco]
>90 [qnco]
Body Weight Gain [fndg]
Decreased [qnco]
Uterine [bpoc]
weight [orga]
Increased [qnco]
High dose [qnco]
Low dose [qnco]
Group [idcn]
eN [gngm]
Face [blor]
Fraction [qnco]
Area [geoa]
Aorta [bpoc]
Covered [ftcn]
atherosclerotic [ftcn]
Decreased [qnco]
High dose [qnco]
Low dose [qnco]
Group [idcn]
Serum cholesterol level [lbpr]
Decreased [qnco]
Low dose [qnco]
Group [idcn]
P NOS [aapp, imft]
P NOS [aapp, imft]
Estradiol [horm, phsu, strd]
treatment [ftcn]
Reduced [qlco]
Fraction [qnco]
atherosclerotic [ftcn]
Area [geoa]
Decreased [qnco]
cholesterol levels [lbpr]
Study [mnob]
2-methoxyestradiol [phsu, strd]
atherosclerotic [ftcn]
formation [biof]
In Vivo [spco]
activity [dora]
Estradiol Receptor [aapp, rcpt]
Metabolite [bacs]
Lacking [qlco]
Estrogen [horm, phsu, strd]
activating [acty]
Capacity [qnco]
Trial [resa]
CARDIOVASCULAR [bdsy]
Hormone replacement therapy [topp]
Estradiol [horm, phsu, strd]
Estrogens [horm, phsu, strd]
Future [tmco]
2-methoxyestradiol [phsu, strd]
Mediator [aapp, bacs]
actions [ftcn]
Estradiol [horm, phsu, strd]
Evaluation [ftcn]
effects [qlco]
2-methoxyestradiol [phsu, strd]
Cardiovascular disease [dsyn]
endpoints [qlco]
ONGOING [idcn]
Clinical Trials [resa]
Great [qnco]
Interest [menp]
